Credit Suisse’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.22M | Sell |
52,724
-22,940
| -30% | -$2.04M | ﹤0.01% | 1389 |
|
|
2023
Q4 | $8.29M | Sell |
75,664
-4,835
| -6% | -$500K | 0.01% | 1027 |
|
|
2023
Q3 | $8.12M | Sell |
80,499
-769
| -0.9% | -$88.4K | 0.01% | 991 |
|
|
2023
Q2 | $11M | Sell |
81,268
-45,383
| -36% | -$5.54M | 0.01% | 879 |
|
|
2023
Q1 | $13.2M | Buy |
126,651
+2,682
| +2% | +$259K | 0.01% | 824 |
|
|
2022
Q4 | $11M | Sell |
123,969
-6,637
| -5% | -$551K | 0.01% | 892 |
|
|
2022
Q3 | $10.5M | Buy |
130,606
+22,810
| +21% | +$2.15M | 0.01% | 888 |
|
|
2022
Q2 | $10.3M | Sell |
107,796
-13,691
| -11% | -$1.64M | 0.01% | 932 |
|
|
2022
Q1 | $18M | Buy |
121,487
+3,235
| +3% | +$452K | 0.02% | 808 |
|
|
2021
Q4 | $16.8M | Buy |
118,252
+10,920
| +10% | +$1.55M | 0.01% | 1181 |
|
|
2021
Q3 | $14M | Buy |
107,332
+9,065
| +9% | +$1.19M | 0.01% | 1310 |
|
|
2021
Q2 | $13.5M | Buy |
98,267
+30,017
| +44% | +$4.11M | 0.01% | 1375 |
|
|
2021
Q1 | $8.91M | Buy |
68,250
+35,882
| +111% | +$4.32M | ﹤0.01% | 1655 |
|
|
2020
Q4 | $3.63M | Buy |
32,368
+11,188
| +53% | +$1.06M | ﹤0.01% | 2359 |
|
|
2020
Q3 | $1.67M | Sell |
21,180
-1,706
| -7% | -$139K | ﹤0.01% | 2559 |
|
|
2020
Q2 | $1.65M | Buy |
22,886
+2,854
| +14% | +$199K | ﹤0.01% | 2537 |
|
|
2020
Q1 | $1.15M | Sell |
20,032
-14,175
| -41% | -$1.31M | ﹤0.01% | 2554 |
|
|
2019
Q4 | $3.83M | Buy |
34,207
+6,700
| +24% | +$714K | ﹤0.01% | 2074 |
|
|
2019
Q3 | $2.64M | Buy |
27,507
+3,062
| +13% | +$287K | ﹤0.01% | 2272 |
|
|
2019
Q2 | $2.09M | Sell |
24,445
-2,069
| -8% | -$170K | ﹤0.01% | 2416 |
|
|
2019
Q1 | $2.21M | Sell |
26,514
-36,361
| -58% | -$2.64M | ﹤0.01% | 2301 |
|
|
2018
Q4 | $4.04M | Buy |
62,875
+40,026
| +175% | +$2.74M | ﹤0.01% | 1737 |
|
|
2018
Q3 | $1.81M | Sell |
22,849
-5,756
| -20% | -$445K | ﹤0.01% | 2422 |
|
|
2018
Q2 | $2.09M | Sell |
28,605
-3,926
| -12% | -$267K | ﹤0.01% | 2414 |
|
|
2018
Q1 | $2.06M | Buy |
32,531
+215
| +0.7% | +$12.8K | ﹤0.01% | 2393 |
|
|
2017
Q4 | $1.65M | Sell |
32,316
-3,754
| -10% | -$196K | ﹤0.01% | 2598 |
|
|
2017
Q3 | $1.89M | Buy |
36,070
+16,157
| +81% | +$811K | ﹤0.01% | 2587 |
|
|
2017
Q2 | $1.01M | Sell |
19,913
-6,858
| -26% | -$339K | ﹤0.01% | 2686 |
|
|
2017
Q1 | $1.19M | Sell |
26,771
-4,057
| -13% | -$175K | ﹤0.01% | 2732 |
|
|
2016
Q4 | $1.36M | Buy |
30,828
+4,448
| +17% | +$189K | ﹤0.01% | 2766 |
|
|
2016
Q3 | $1.06M | Buy |
26,380
+3,146
| +14% | +$134K | ﹤0.01% | 2909 |
|
|
2016
Q2 | $1.11M | Buy |
23,234
+3,768
| +19% | +$160K | ﹤0.01% | 2832 |
|
|
2016
Q1 | $816K | Buy |
19,466
+4,359
| +29% | +$171K | ﹤0.01% | 2879 |
|
|
2015
Q4 | $666K | Sell |
15,107
-7,787
| -34% | -$338K | ﹤0.01% | 3149 |
|
|
2015
Q3 | $1.09M | Buy |
22,894
+6,043
| +36% | +$332K | ﹤0.01% | 2742 |
|
|
2015
Q2 | $981K | Buy |
16,851
+3,853
| +30% | +$208K | ﹤0.01% | 3203 |
|
|
2015
Q1 | $656K | Sell |
12,998
-2,171
| -14% | -$106K | ﹤0.01% | 3343 |
|
|
2014
Q4 | $683K | Sell |
15,169
-9,130
| -38% | -$383K | ﹤0.01% | 3469 |
|
|
2014
Q3 | $896K | Sell |
24,299
-67,404
| -74% | -$2.67M | ﹤0.01% | 3152 |
|
|
2014
Q2 | $4.05M | Buy |
91,703
+43,986
| +92% | +$1.99M | ﹤0.01% | 2144 |
|
|
2014
Q1 | $2.07M | Buy |
47,717
+27,969
| +142% | +$1.25M | ﹤0.01% | 2481 |
|
|
2013
Q4 | $839K | Sell |
19,748
-10,046
| -34% | -$382K | ﹤0.01% | 3410 |
|
|
2013
Q3 | $1.01M | Buy |
29,794
+2,652
| +10% | +$86.5K | ﹤0.01% | 2951 |
|
|
2013
Q2 | $847K | Buy |
+27,142
| New | +$881K | ﹤0.01% | 2924 |
|
Other funds holding CNMD
CIP
WHG
Credit Suisse's CNMD Position: Q1 2024 in Review
Credit Suisse reduced its CONMED (CNMD) stake by 30% in Q1 2024, selling an estimated $2.04M and leaving 52,724 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1389.
Credit Suisse first reported a position in CNMD in Q2 2013 and has held it in 44 quarters since. The position peaked at $18M in Q1 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.
- Credit Suisse held 52,724 shares of CONMED worth $4.22M as of Q1 2024.
- Credit Suisse sold 22,940 CONMED shares in Q1 2024, an estimated $2.04M.
- CONMED made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1389 holding.
- Credit Suisse first reported a position in CONMED in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's CONMED position peaked at $18M in Q1 2022.
- 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.